207940.KS
Samsung Biologics Co.,Ltd.
KSC · Healthcare · Biotechnology · KR
KRW 1,477,000.00
−1.60%Leverage
- Debt / equity
- 0.15x
- Net debt / equity
- 0.11x
- Debt / assets
- 0.10x
- Debt / EBITDA
- 0.42x
- Net debt / EBITDA
- 0.32x
Liquidity & coverage
- Current ratio
- 1.80x
- Quick ratio
- 1.01x
- Cash ratio
- 0.74x
- Interest coverage
- 73.83x
- EBITDA / interest
- 109.76x
- Working capital
- KRW 2.36T
Cash & dividend
- FCF / debt
- 1.30x
- Cash flow / debt
- 1.96x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026